NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: WHO IS THE WINNER?

被引：0
|
作者：
Celsa, C. [1 ]
Cabibbo, G. [1 ]
Rizzo, G. E. M. [1 ]
Giuffrida, P. [1 ]
Di Maria, G. [1 ]
Battaglia, S. [2 ]
Vaccaro, M. [1 ]
Enea, M. [1 ]
Giacchetto, C. M. [1 ]
Rancatore, G. [1 ]
Grassini, M., V [1 ]
Ciccia, R. [1 ]
Grova, A. [1 ]
Salvato, M. [1 ]
Camma, C. [1 ]
机构：
[1] Univ Palermo, Sect Gastroenterol & Hepatol, PROMISE Dept, Palermo, Italy
[2] Univ Palermo, Palermo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.08.2
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [21] Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
    Shao, Yu-Yun
    Wu, Chih-Horng
    Lu, Li-Chun
    Chan, Soa-Yu
    Ma, Yu-Yi
    Yen, Feng-Chu
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 313 - 318
  • [22] First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States
    Sun, Ke-Xin
    Cao, Shan-Shan
    Shi, Feng-Hao
    Guan, Yue
    Tang, Meng
    Zhao, Mei-na
    Jian, Yu-Fan
    Cui, Bin
    Li, Zhi-Yan
    Wang, Jing-Wen
    Yu, Feng
    Ding, Yi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [23] Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
    Oranratnachai, Songporn
    Rattanasiri, Sasivimol
    Pooprasert, Anantaporn
    Tansawet, Amarit
    Reungwetwattana, Thanyanan
    Attia, John
    Thakkinstian, Ammarin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials
    Cucchetti, Alessandro
    Piscaglia, Fabio
    Pinna, Antonio Daniele
    Djulbegovic, Benjamin
    Mazzotti, Federico
    Bolondi, Luigi
    LIVER CANCER, 2017, 6 (04) : 337 - 348
  • [25] First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
    Cheng, Ji
    Cai, Ming
    Shuai, Xiaoming
    Gao, Jinbo
    Wang, Guobin
    Tao, Kaixiong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [26] First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials
    Ding, Wei
    Tan, Yulin
    Qian, Yan
    Xue, Wenbo
    Wang, Yibo
    Jiang, Peng
    Xu, Xuezhong
    PLOS ONE, 2020, 15 (03):
  • [27] The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Huang, Yi-Jie
    Peng, Yen-Chun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [28] First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
    Liu, Wenfeng
    Quan, Bing
    Lu, Shenxin
    Tang, Bei
    Li, Miao
    Chen, Rongxin
    Ren, Zhenggang
    Yin, Xin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
    Ridouane, Yassine
    Lopes, Gilberto
    Ku, Geoffrey
    Masud, Hasan
    Haaland, Benjamin
    ONCOTARGET, 2017, 8 (39) : 66458 - 66466
  • [30] Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
    Luo, Jia
    Gao, Benjian
    Lin, Zhiyu
    Fan, Hua
    Ma, Wen
    Yu, Danfei
    Yang, Qian
    Tian, Jing
    Yang, Xiaoli
    Li, Bo
    FRONTIERS IN ONCOLOGY, 2022, 12
12345